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A B S T R A C T
Introduction: To disentangle the association between impulsive and compulsive behaviors (ICBs), health-related
quality of life (HRQOL), satisfaction with life (SwL), and caregiver distress in dyads of people with Parkinson's
disease (PwP) and caregivers.
Methods: Data used in this study were obtained from the ongoing Norwegian ParkWest study, a population-
based longitudinal cohort study of the incidence, neurobiology and prognosis of PD in Western Norway. One
hundred and one dyads of PwP free of dementia and their caregivers were included 5 years after PD diagnosis
and inclusion in the ParkWest study. Standardized clinical rating scales were used to evaluate ICBs, HRQOL, SwL
and caregiver distress.
Results: Of 101 PwP-caregiver dyads, self-reported ICBs were seen in 33% of PwP and only caregiver-reported
ICBs in 12% of PwP. PwP-reported ICBs were associated with poorer HRQOL and SwL, whereas ICBs reported by
caregivers only were associated with increased caregiver distress, but not poorer HRQOL or SwL in PwP.
Conclusions: ICBs have adverse effects on HRQOL, SwL and caregiver distress. These findings underpin the need
for proper identification and management of ICBs in PwP.
1. Introduction
Impulsive and compulsive behaviors (ICBs) are common among
people with Parkinson's disease (PwP) [1]. These non-motor symptoms
are characterized by difficulties resisting the impulse, drive or temp-
tation for a behavior, and may have adverse effects on the quality of life
of PwP and potentially severe interpersonal consequences [2–5]. In PD,
ICBs are closely associated with the use of dopamine agonists, with the
risk being most prominent in younger PwP, early onset PD, male
gender, tobacco use or history with other addictions [1].
Due to the association between ICB development and dopaminergic
treatment [1], frequent screening of these behaviors is recommended.
However, screening is not always straightforward in clinical practice, as
it relies on the self-assessment of PwP who may lack insight into the
frequency, severity and consequences of their own behavior [6,7]. ICBs
may also function as a coping strategy for the existential and personal
crises that often follow the diagnosis of a chronic disease [7]. Affected
PwP may also avoid disclosing these symptoms to their physician,
family and caregivers, due to the stigma and interpersonal con-
sequences that may follow disclosing these behaviors. Caregivers may
carry the burden of these behavioral disorders, especially if the beha-
viors are pronounced, but not acknowledged, by the person with ICBs.
Thus, the personal and interpersonal consequences of ICBs may differ
widely between PwP and caregivers. In this study, we therefore ex-
plored the impact of ICB presence on the quality of and satisfaction with
life in PwP, and caregiver distress.
2. Methods
2.1. Study design and participants
We used data from the ongoing Norwegian ParkWest project, a
population-based longitudinal study of incident PD. Details of the case
ascertainment and diagnostic procedures to recruit a population-re-
presentative PD cohort have been published elsewhere [8]. In short,
212 newly diagnosed, drug naïve PwP were recruited from four
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counties in Norway between 2004 and 2006, and followed pro-
spectively by movement disorder neurologists. As previously reported,
screening for ICBs was first introduced after five years of follow up,
where 124 PwP remained in the study [9]. In this cross-sectional study,
complete datasets from 101 PwP free from dementia and their care-
givers was used. Among caregivers, 73.3% were spouses, 19.8% were
1st degree relatives, and 6.9% categorized as “other caregivers”. The
study was approved by the Regional Committee for Medical and Health
Research Ethics, Western Norway. Signed written informed consent was
obtained from all participants.
2.2. Assessments
A standardized examination program was administered by trained
members of the ParkWest study group. Information regarding demo-
graphic variables, lifestyle factors, clinical history, and medication was
obtained from semi-structured interviews. Motor severity and disease
stage were assessed by the Unified PD Rating Scale (UPDRS) and the
Hoehn and Yahr staging. Global cognitive function was evaluated using
the Mini-Mental State Examination (MMSE), and depressive symptoms
were evaluated using the Montgomery and Asberg Depression Rating
Scale (MADRS). The self-report and informant version of the
Questionnaire for Impulsive-Compulsive Disorders in PD – Short form
(QUIP) was used to assess ICBs in PwP [10]. We categorized PwP as “No
ICBs” when neither patients nor caregivers reported ICBs on QUIP, as
“Self-reported ICBs” when PwP reported ICBs on QUIP, and as “Only
caregiver-reported ICBs” when caregivers, but not PwP reported ICBs
on QUIP. Due to the limited number of cases where PwP and caregivers
(N = 9) agreed in their rating of ICBs, these cases were included in the
“Self-reported ICBs”.
The 36-item RAND Health Status Inventory (RAND-HSI), a generic
self-report measure of functional health and well-being recommended
for use in PwP, was used to measure health-related quality of life
(HRQOL) [11,12]. The measure evaluates eight domains of HRQOL,
and includes three composite scores; physical health, mental health,
and global health. For this study, the Global Health Composite (GHC)
score of the RAND-HSI was used. In addition, the 5-item Satisfaction
With Life Scale (SWLS) was used to measure the life satisfaction com-
ponent of subjective well-being [13,14]. Caregiver distress was mea-
sured using the Relatives’ Stress Scale (RSS), a 15-item self-report
measure commonly used to assess caregiver distress in geriatric patient
populations [15,16]. RSS is scored on a 5-level Likert scale, ranging
from 0 = “not at all” to 4 = “to a high degree”, and a sum-score can be
derived as a measure of the level of overall caregiver stress.
2.3. Statistical methods
All statistical procedures were performed using IBM SPSS Statistics
for Windows, Version 24.0. Armonk, NY: IBM Corp. Univariate group
differences in demographic and clinical variables were explored using
general linear modeling (GLM). Multivariate GLM was used to in-
vestigate the relationship between ICB status and scores of HRQOL,
SwL, and caregiver distress. In these analyses, separate models with
RAND-HSI GHC, SWLS and RSS scores as dependent variables were
performed. In each model, age, sex, duration of PD (years), UPDRS
motor score, MADRS score, and ICB category (“No ICBs” was used as
the reference category) were entered as independent variables. Simple
planned contrasts were estimated to further differentiate between the
groups in the multivariate analyses. Two-tailed p values < 0.05 were
considered statistically significant.
3. Results
Demographic and clinical characteristics of the PwP are presented
in Table 1. Overall, ICBs were reported by either PwP or caregivers in
45 (44.6%) of the 101 cases, whereas 56 (55.4%) cases had no ICBs.
Compared to PwP without ICBs, PwP with self-reported ICBs were
significantly younger (B = −5.8; p = 0.003; 95% CI -9.5 to −2.0) and
had higher MADRS (B = 2.9, p = 0.003; 95% confidence interval [CI]
1.0 to 4.8) and RSS scores (B = 6.6, p = 0.001; 95% CI 2.9 to 10.4), but
lower RAND-HSI GHC (B = −8.1, p = 0.003; 95% CI -13.4 to −2.8))
and SWLS (B = −4.5, p = 0.001; 95% CI -7.2 to −1.8) scores. In
contrast, PwP with only caregiver-reported ICBs had higher RSS scores
(B = 8.6, p = 0.002; 95% CI 3.1 to 14.1) than PwP without ICBs, but
did not differ on other measures.
The results from the GLM analyses are shown in Table 2. There was
a negative association between PwP-reported ICBs and RAND-HSI GHC
(B = −5.3, p = 0.016, 95% CI -9.5 to −1.0) and SWLS (B = −3.7,
p = 0.014, 95% CI -6.6 to −0.7) scores, and a positive association
between only caregiver-reported ICBs and RSS scores (B = 8.9,
p = 0.001, 95% CI 3.6 to 14.2), independent of potential confounders.
4. Discussion
In this study, we demonstrate that PwP-reported ICBs are associated
with poorer quality of and satisfaction with life in PwP themselves, but
not increased caregiver burden. In contrast, only caregiver-reported
ICBs were associated with increased levels of distress among caregivers,
but not poorer quality of and satisfaction with life in PwP. This high-
lights the importance of proper identification and management strate-
gies of ICBs in PwP and their caregivers.
To our knowledge, this is so far the first investigation of both sub-
jective well-being and quality of life in PwP with and without ICBs. In
order to investigate the full range of these modalities, we included the
RAND-HSI and SWLS. Although these measures often correlate, they
represent different modalities of quality of life and well-being, and may
be influenced differently by motor and non-motor symptoms of PD. In
our study, both measures were associated with self-reported ICBs after
adjusting for potential confounders. Although previous studies have
reported an associated between ICBs and HRQOL in PwP [2,4], this
association may have been an artifact of increased depressive symptoms
in PwP with ICBs [3]. In this study, we demonstrate an independent
effect of ICBs on HRQOL and SwL even after adjustment for depressive
symptomatology. Interestingly, the effect on HRQOL and SwL was only
evident in PwP-reported ICB cases, but not in ICB cases reported by
caregivers only.
Our data, however, identifies increased caregiver distress among
PwP with only caregiver-reported ICBs. This finding highlights the
importance of “insight” for PwP with ICBs, and mirrors a common
clinical observation; i.e. caregiver distress is most prominent when the
caregiver consider the behavior of the PwP as troublesome, but the PwP
does not agree or have insight into the severity of his or her behavior.
Although this finding has important clinical implications, it may be
confounded by other important clinical factors not included in this
study, such as cognitive deficits or depression [17,18]. We did not find
significant differences on MMSE or MADRS in our data, both depression
and cognitive deficits have impact on self-evaluation, insight and ability
to self-report [19]. This is supported by evidence from a recent clinical
trial of cognitive behavioral therapy for ICBs, where a reduction of
severity of ICBs was associated with a decrease in the severity of de-
pressive symptoms [20].
These findings are relevant for both clinical practice and future
research. The negative effect of ICBs on subjective well-being argue for
the development of clinical practices that aid PwP in addressing ICBs
with their neurologist. Strategies such as the involvement of caregivers
in the long-term management of PD, and the use of full diagnostic in-
terviews with regards to ICBs, may increase the probability of patients
disclosing ICBs during clinical examinations [6]. Furthermore, con-
tinued development of non-pharmacological treatment strategies that
can assist PwP and their caregivers in managing ICBs and its con-
sequences is necessary. This includes interventions that reduce the risk
of relational and marital crises that often follow ICBs. Cognitive
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behavioral therapy (CBT) have shown promise as a treatment that both
benefit PwP and their caregivers [20].
The major strengths of this study are the population-based design,
the use of multiple validated scales of life satisfaction, and the inclusion
of caregivers in the evaluation of ICBs. Limitations include the cross-
sectional data, the limited size of ICB groups not allowing for in-depth
analyses, and the use of MMSE as a measure of global cognitive func-
tioning. However, this study is exploratory in nature, and our findings
should therefore be replicated in larger cohorts of PwP-caregiver dyads,
including a larger array of possible neuropsychiatric correlates. Future
studies should also aim to further differentiate between individual ICBs
and their effect on QoL and caregiver distress in PwP.
Search terms
Parkinson's disease, impulse control disorders, quality of life, sa-
tisfaction with life, caregiver burden.
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